Furthermore, in contrast to other oncogenes like MOZ-TIF2 and MLL-ENL, BCR-ABL cannot confer self-renewal properties on committed progenitor cells, again suggesting that immature stem/progenitor cells are most likely the cell of origin in CML [13–15]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.